All news updates:

HERAN Partners is pleased to announce its investment in ImmuneSpec, a Company at the forefront of advanced immunopeptidomics. The EUR 1,2m seed funding from HERAN HealthTech Fund I will enable ImmuneSpec to accelerate the further optimisation and commercial roll-out of their advanced immunopeptidomics analysis platform.

Want to make your SME or start-up more sustainable, but don't have the resources for a sustainability manager? During a recent double interview with Trends magazine, Charlotte Vandierendonck of the consulting firm Studio D and HERAN Partners managing director Katleen Vandersmissen answered six questions to help you get started.

The additional raised capital will be used to scale up the company’s operations, accelerate the development of new application areas and further boost commercialization.

EIC grant to accelerate the market introduction of unique EV analysis and isolation application.

Filip Maes supports the HERAN team in identifying & onboarding innovative start-ups and scale-ups by leveraging his strong scientific background.

Inspiring insights from HERAN's Investor Day

LynxCare's AI platform based on hospital data can improve patient care and stimulate research, Amaron provides software to unlock hospital data in a secure and efficient way.

Human Capital: Meet our Investment Director

10th Investment of HERAN HealthTech Fund I